- Details
- Description
Packaging Size:
30t/bottle
Strength:
50mg
Composition:
Orelabrutinib
Treatment:
Mantle cell lymphoma (MCL) and Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Form:
Tablet
Brand:
宜诺凯（INNOBRUKA）
Quantity Unit:
50mg*30t/Box
Manufacturer:
InnoCare Pharma.,China
Orelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety.
- Orelabrutinib sold under the brand name 宜诺凯（INNOBRUKA）® in china.
In China, it is approved for patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), who have received at least one treatment in the past.
